{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:05:01Z","timestamp":1781525101910,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the 2024 Key Scientific and Technological Project of Henan Science and Technology Department","award":["242102311141"],"award-info":[{"award-number":["242102311141"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02647-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:34:18Z","timestamp":1752140058000},"page":"2337-2350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["METTL3 overexpression and ATF6 silencing-induced Inhibition in HAS2 expression relieves PDGF-BB stimulation-induced HA production and the proliferation of human orbital fibroblasts in graves\u2019 ophthalmopathy"],"prefix":"10.1007","volume":"48","author":[{"given":"Shu-Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Fei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"2647_CR1","first-page":"621","volume":"57","author":"E Kardalas","year":"2021","unstructured":"Kardalas E, Maraka S, Papagianni M, Paltoglou G, Siristatidis C, Mastorakos G (2021) TGF-\u03b2 physiology as a novel therapeutic target regarding autoimmune thyroid diseases: where do we stand and what to expect. Med (Kaunas) 57:621","journal-title":"Med (Kaunas)"},{"key":"2647_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ophtha.2007.07.027","volume":"115","author":"RV Gaddipati","year":"2008","unstructured":"Gaddipati RV, Meyer DR (2008) Eyelid retraction, lid lag, lagophthalmos, and von graefe\u2019s sign quantifying the eyelid features of graves\u2019 ophthalmopathy. Ophthalmology 115:1083\u20131088","journal-title":"Ophthalmology"},{"key":"2647_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/cells13171493","volume":"13","author":"HH Chang","year":"2024","unstructured":"Chang HH, Wu SB, Tsai CC (2024) A review of pathophysiology and therapeutic strategies targeting TGF-\u03b2 in graves\u2019 ophthalmopathy. Cells 13:1493","journal-title":"Cells"},{"key":"2647_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","volume":"33","author":"Y Huang","year":"2019","unstructured":"Huang Y, Fang S, Li D, Zhou H, Li B, Fan X (2019) The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye (Lond) 33:176\u2013182","journal-title":"Eye (Lond)"},{"key":"2647_CR5","doi-asserted-by":"publisher","first-page":"e001515","DOI":"10.1136\/bmjophth-2023-001515","volume":"9","author":"OM Bello","year":"2024","unstructured":"Bello OM, Druce M, Ansari E (2024) Graves\u2019 ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review. BMJ Open Ophthalmol 9:e001515","journal-title":"BMJ Open Ophthalmol"},{"key":"2647_CR6","doi-asserted-by":"publisher","first-page":"e2400542","DOI":"10.1002\/smll.202400542","volume":"20","author":"F Zhou","year":"2024","unstructured":"Zhou F, Chen M, Qian Y, Yuan K, Han X, Wang W et al (2024) Enhancing endogenous hyaluronic acid in Osteoarthritic joints with an Anti-Inflammatory supramolecular nanofiber hydrogel delivering HAS2 lentivirus. Small 20:e2400542","journal-title":"Small"},{"key":"2647_CR7","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1042\/BCJ20180054","volume":"475","author":"L Rauhala","year":"2018","unstructured":"Rauhala L, Jokela T, K\u00e4rn\u00e4 R, Bart G, Takabe P, Oikari S et al (2018) Extracellular ATP activates hyaluronan synthase 2 (HAS2) in epidermal keratinocytes via P2Y(2), Ca(2+) signaling, and MAPK pathways. Biochem J 475:1755\u20131772","journal-title":"Biochem J"},{"key":"2647_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.0022-202X.2005.23697.x","volume":"124","author":"R Tammi","year":"2005","unstructured":"Tammi R, Pasonen-Sepp\u00e4nen S, Kolehmainen E, Tammi M (2005) Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J Invest Dermatol 124:898\u2013905","journal-title":"J Invest Dermatol"},{"key":"2647_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/molecules28010015","volume":"28","author":"E Galgoczi","year":"2022","unstructured":"Galgoczi E, Katko M, Papp FR, Csiki R, Csiha S, Erdei A et al (2022) Glucocorticoids directly affect hyaluronan production of orbital fibroblasts; A potential pleiotropic effect in graves\u2019 orbitopathy. Molecules 28:15","journal-title":"Molecules"},{"key":"2647_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1945892420932781","volume":"35","author":"Y Hirata","year":"2021","unstructured":"Hirata Y, Kariya S, Kanai K, Fujiwara T, Makihara SI, Omichi R et al (2021) Effect of prostaglandin D(2) on mRNA expression of three isoforms of hyaluronic acid synthase in nasal polyp fibroblasts. Am J Rhinol Allergy 35:44\u201351","journal-title":"Am J Rhinol Allergy"},{"key":"2647_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1165\/rcmb.2017-0095OC","volume":"57","author":"JKL Walker","year":"2017","unstructured":"Walker JKL, Theriot BS, Ghio M, Trempus CS, Wong JE, McQuade VL et al (2017) Targeted HAS2 expression lessens airway responsiveness in chronic murine allergic airway disease. Am J Respir Cell Mol Biol 57:702\u2013710","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2647_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.matbio.2016.11.003","volume":"62","author":"VK Krishnamurthy","year":"2017","unstructured":"Krishnamurthy VK, Stout AJ, Sapp MC, Matuska B, Lauer ME, Grande-Allen KJ (2017) Dysregulation of hyaluronan homeostasis during aortic valve disease. Matrix Biol 62:40\u201357","journal-title":"Matrix Biol"},{"key":"2647_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41417-020-00218-z","volume":"28","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu T, Li T, Zhao X (2021) Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p\/HAS2 axis. Cancer Gene Ther 28:279\u2013293","journal-title":"Cancer Gene Ther"},{"key":"2647_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5483\/BMBRep.2021.54.2.178","volume":"54","author":"HK Yoo","year":"2021","unstructured":"Yoo HK, Park H, Hwang HS, Kim HJ, Choi YH, Kook KH (2021) Ganglioside GT1b increases hyaluronic acid synthase 2 via PI3K activation with TLR2 dependence in orbital fibroblasts from thyroid eye disease patients. BMB Rep 54:136\u2013141","journal-title":"BMB Rep"},{"key":"2647_CR15","doi-asserted-by":"publisher","first-page":"111045","DOI":"10.1016\/j.cbi.2024.111045","volume":"396","author":"E Galgoczi","year":"2024","unstructured":"Galgoczi E, Molnar Z, Katko M, Ujhelyi B, Steiber Z, Nagy EV (2024) Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts. Chem Biol Interact 396:111045","journal-title":"Chem Biol Interact"},{"key":"2647_CR16","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C (2021) m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J 40:e105977","journal-title":"EMBO J"},{"key":"2647_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","volume":"22","author":"SW Yue","year":"2023","unstructured":"Yue SW, Liu HL, Su HF, Luo C, Liang HF, Zhang BX et al (2023) m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Mol Cancer 22:137","journal-title":"Mol Cancer"},{"key":"2647_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13:117","journal-title":"J Hematol Oncol"},{"key":"2647_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L et al (2014) A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 10:93\u201395","journal-title":"Nat Chem Biol"},{"key":"2647_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","volume":"24","author":"E Sch\u00f6ller","year":"2018","unstructured":"Sch\u00f6ller E, Weichmann F, Treiber T, Ringle S, Treiber N, Flatley A et al (2018) Interactions, localization, and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex. RNA 24:499\u2013512","journal-title":"RNA"},{"key":"2647_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74","journal-title":"Signal Transduct Target Ther"},{"key":"2647_CR22","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1093\/nar\/gkab378","volume":"49","author":"S Oerum","year":"2021","unstructured":"Oerum S, Meynier V, Catala M, Tisn\u00e9 C (2021) A comprehensive review of m6A\/m6Am RNA methyltransferase structures. Nucleic Acids Res 49:7239\u20137255","journal-title":"Nucleic Acids Res"},{"key":"2647_CR23","doi-asserted-by":"publisher","first-page":"666393","DOI":"10.3389\/fendo.2021.666393","volume":"12","author":"RH Song","year":"2021","unstructured":"Song RH, Du P, Gao CQ, Liu XR, Zhang JA (2021) METTL3 is involved in the development of graves\u2019 disease by inducing SOCS mRNA m6A modification. Front Endocrinol (Lausanne) 12:666393","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2647_CR24","doi-asserted-by":"publisher","first-page":"116354","DOI":"10.1016\/j.biopha.2024.116354","volume":"173","author":"B He","year":"2024","unstructured":"He B, Hu Y, Cao Q, Li Y, Tang Y, Cao T et al (2024) Progression of unfolded protein response and ferroptosis in angiogenesis. Biomed Pharmacother 173:116354","journal-title":"Biomed Pharmacother"},{"key":"2647_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature17041","volume":"529","author":"M Wang","year":"2016","unstructured":"Wang M, Kaufman RJ (2016) Protein misfolding in the Endoplasmic reticulum as a conduit to human disease. Nature 529:326\u2013335","journal-title":"Nature"},{"key":"2647_CR26","doi-asserted-by":"publisher","first-page":"1001349","DOI":"10.3389\/fendo.2022.1001349","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, Chen M, Liang Y, Hu Y, Xia W, Zhang Y et al (2022) Integrative metabolic analysis of orbital adipose\/connective tissue in patients with thyroid-associated ophthalmopathy. Front Endocrinol (Lausanne) 13:1001349","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2647_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(16)30046-8","volume":"5","author":"WM Wiersinga","year":"2017","unstructured":"Wiersinga WM (2017) Advances in treatment of active, moderate-to-severe graves\u2019 ophthalmopathy. Lancet Diabetes Endocrinol 5:134\u2013142","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2647_CR28","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1210\/clinem\/dgaa684","volume":"106","author":"R Fernando","year":"2021","unstructured":"Fernando R, Smith TJ (2021) Slit2 regulates hyaluronan & cytokine synthesis in fibrocytes: potential relevance to Thyroid-Associated ophthalmopathy. J Clin Endocrinol Metab 106:e20\u2013e33","journal-title":"J Clin Endocrinol Metab"},{"key":"2647_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12020-023-03382-y","volume":"82","author":"R Liu","year":"2023","unstructured":"Liu R, Ye Z, Liu Q, Xuan M, Li R, Zhang L et al (2023) MicroRNA-376b is involved in the pathogenesis of thyroid-associated ophthalmopathy by regulating HAS2. Endocrine 82:87\u201395","journal-title":"Endocrine"},{"key":"2647_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.7.28","volume":"64","author":"Y Guo","year":"2023","unstructured":"Guo Y, Cheng Y, Li H, Guan H, Xiao H, Li Y (2023) The potential of artemisinins as novel treatment for thyroid eye disease by inhibiting adipogenesis in orbital fibroblasts. Invest Ophthalmol Vis Sci 64:28","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2647_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.62.12.18","volume":"62","author":"H Lou","year":"2021","unstructured":"Lou H, Wu LQ, Wang H, Wei RL, Cheng JW (2021) The potential role of osteopontin in the pathogenesis of graves\u2019 ophthalmopathy. Invest Ophthalmol Vis Sci 62:18","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2647_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12020-020-02503-1","volume":"72","author":"RH Song","year":"2021","unstructured":"Song RH, Liu XR, Gao CQ, Du P, Zhang JA (2021) METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease. Endocrine 72:495\u2013504","journal-title":"Endocrine"},{"key":"2647_CR33","doi-asserted-by":"publisher","first-page":"e13157","DOI":"10.1111\/cpr.13157","volume":"55","author":"J Li","year":"2022","unstructured":"Li J, Chen K, Dong X, Xu Y, Sun Q, Wang H et al (2022) YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation. Cell Prolif 55:e13157","journal-title":"Cell Prolif"},{"key":"2647_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-024-01959-8","volume":"10","author":"J Wang","year":"2024","unstructured":"Wang J, Yin H, Li G, Wu D, Xu Y, Chen Y et al (2024) METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism. Cell Death Discov 10:186","journal-title":"Cell Death Discov"},{"key":"2647_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-018-0453-1","volume":"25","author":"RF Hillary","year":"2018","unstructured":"Hillary RF, FitzGerald U (2018) A lifetime of stress: ATF6 in development and homeostasis. J Biomed Sci 25:48","journal-title":"J Biomed Sci"},{"key":"2647_CR36","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.3390\/ijms21176127","volume":"21","author":"R Ghemrawi","year":"2020","unstructured":"Ghemrawi R, Khair M (2020) Endoplasmic reticulum stress and unfolded protein response in neurodegenerative diseases. Int J Mol Sci 21:6127","journal-title":"Int J Mol Sci"},{"key":"2647_CR37","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.18632\/aging.101949","volume":"11","author":"W Yang","year":"2019","unstructured":"Yang W, Sheng F, Sun B, Fischbach S, Xiao X (2019) The role of ORMDL3\/ATF6 in compensated beta cell proliferation during early diabetes. Aging 11:2787\u20132796","journal-title":"Aging"},{"key":"2647_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-22-0102","volume":"21","author":"A McMellen","year":"2023","unstructured":"McMellen A, Yamamoto TM, Qamar L, Sanders BE, Nguyen LL, Ortiz Chavez D et al (2023) ATF6-Mediated signaling contributes to PARP inhibitor resistance in ovarian Cancer. Mol Cancer Res 21:3\u201313","journal-title":"Mol Cancer Res"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02647-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:41:05Z","timestamp":1760362865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02647-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2647"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02647-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}